Herring WL, Gould IG, Wittrup-Jensen V, Ertle J, Kuti E, Wolowacz S. Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes. J Comp Eff Res. 2022 Dec 1;11(18):1349-63. doi: 10.2217/cer-2021-0194
Power JEM, Feeney J, Fowler E, McMichael AJ, Hyland P, Lawlor BA, Cruise S, Potter C, Young I, McGuinness B, Kee F. Exposure to the troubles in Northern Ireland, memory functioning, and social activity engagement: results from NICOLA. Eur J Ageing. 2022 Feb 10. doi: 10.1007/s10433-022-00683-5
Burton AE, Dean SE, Demeyin (Nuabor) W, Reeves J. Questionnaire measures of self-directed ageing stereotype in older adults: a systematic review of measurement properties. Eur J Ageing. 2020 Jul 12. doi: 10.1007/s10433-020-00574-7
Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 Aug;7(8):723-35. doi: 10.2217/cer-2018-0003
Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039